Texas has reached an $84 million settlement with a prescription drug maker convicted of inflating drug prices to the Medicaid program.
State Attorney General Greg Abbott said the agreement averts lengthy appeals after a Travis County jury verdict in February. Prosecutors argued Actavis Inc. inaccurately reported its prices, leading Medicaid to overpay pharmacies.
CEO Doug Boothe said Wednesday his New Jersey-based company was pleased to resolve the case and would continue to report prices legally and under terms of the agreement.
The latest news from around North Texas.
The lawsuit followed a whistleblower suit filed more than 10 years ago by a small pharmacy in Florida and was the only one of several similar cases to reach a jury.
About $30 million of the settlement gets returned to the Texas treasury after legal fees and federal reimbursements.